- ECHA
- Konsultazzjonijiet
- Konsultazzjoni dwar deroga għall-kriterju ta’ esklużjoni
- Konsultazzjonijiet preċedenti dwar deroga għall-kriterji ta’ esklużjoni
Konsultazzjonijiet preċedenti dwar deroga għall-kriterji ta’ esklużjoni
Konsultazzjonijiet preċedenti dwar deroga għall-kriterji ta’ esklużjoni
The closed consultations on the derogations to the exclusion criteria as laid down in Article 5(2) of the BPR are listed in the table below.
There are currently no ongoing consultations.
1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole (Propiconazole) | 8 | 262-104-4 | 60207-90-1 | 17/06/2022 | 15/08/2022 | Details |
2,2-dibromo-2-cyanoacetamide (DBNPA) | PT 6 | 233-539-7 | 10222-01-2 | 03/11/2023 | 04/01/2024 | Details |
2,2-dibromo-2-cyanoacetamide; [DBNPA] | 4 | 233-539-7 | 10222-01-2 | 11/10/2019 | 10/12/2019 | Details |
Cholecalciferol | 14 | 200-673-2 | 67-97-0 | 01/02/2024 | 25/04/2024 | Details |
Cholecalciferol | 14 | 200-673-2 | 67-97-0 | 01/02/2018 | 01/04/2018 | Details |
Creosote | PT08 | 232-287-5 | 8001-58-9 | 29/01/2021 | 30/03/2021 | Details |
Reaction products of paraformaldehyde and 2- hydroxypropylamine (ratio 1:1) (originally notified as HPT) | 2, 6, 11, 13 | - | - | 04/09/2017 | 04/11/2017 | Details |
Reaction products of paraformaldehyde and 2- hydroxypropylamine (ratio 3:2) (originally notified as MBO) | 2, 6, 11, 12, 13 | - | - | 04/09/2017 | 04/11/2017 | Details |